Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The J3420 modifier provides additional details about the procedure, ensuring that the insurance company processes the claim accurately.
S2CID 225058557
It is important to consult with a healthcare professional to determine if you qualify for this treatment
Patients with non-alcoholic steatohepatitis (NASH) or non-alcoholic fatty liver disease (NAFLD) with concurrent diabetes or obesity might benefit from the hepatic anti-inflammatory effects observed in clinical studies, though GLP-1 receptor agonists are not yet FDA-approved specifically for liver disease
Sleep improvements often come within 2 to 4 weeks
US$ 21.55
US$ 26.72
US$ 23.60
